ArticleFrontiers in immunology2026
A machine learning integrated multi-omics framework for risk prediction and target discovery in insomnia aggravated sepsis induced acute lung injury.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to identify critical biomarkers and clarify how insomnia exacerbates sepsis-induced acute lung injury (SALI). We used integrative multi-omics approaches and machine learning. Methods: A causal association between sepsis and insomnia was established using Mendelian randomization (MR). We used weighted gene co-expression network analysis (WGCNA) to identify genes linked to both insomnia and SALI. We used machine learning techniques (Random Forest, SVM, KNN) with SHAP interpretability modeling to refine gene signatures. The diagnostic and prognostic value of these genes was investigated. To elucidate the underlying molecular pathways, functional enrichment analyses, including KEGG, GO, PPI, and GSEA were performed. To validate gene expression patterns and cellular localization, transcriptomic profiling, single-cell RNA sequencing (scRNA-seq), and Results: MR analysis identified insomnia as a causal determinant in susceptibility to sepsis. Complementary pathological evidence from preclinical sleep deprivation models further confirmed its role in exacerbating progression of SALI. The WGCNA revealed 1,294 co-dysregulated genes shared between insomnia and SALI. These genes were significantly enriched in biological processes, including immune regulation and phagocytic vesicle formation, as well as KEGG pathways such as tuberculosis infection and chemokine signaling. Among these,102 genes exhibited differential expression in a murine SALI model induced by LPS. Through machine learning analysis, ISG20, MYO1F, and PTPN6 were identified as robust hub genes. Further diagnostic stratification and prognostic evaluation prioritized PTPN6 as the most promising candidate. Immune infiltration analysis, scRNA-seq profiling and GSEA collectively demonstrated that PTPN6 expression is predominantly localized to macrophages and functionally involved in modulating the JAK/STAT3 signaling pathway. Functional validation via PTPN6 overexpression in macrophages confirmed its suppressive effects on pro-inflammatory cytokine production, STAT3 phosphorylation, and M1 polarization. Conclusion: This work identifies PTPN6 as a critical biomarker mechanistically linking insomnia to an exacerbation of SALI, potentially through the amplification of pro-inflammatory responses and JAK/STAT3-dependent macrophage polarization. These findings enhance our understanding of the molecular processes underlying this pathogenic axis; however, further mechanistic investigations and comprehensive clinical validation are required to fully elucidate the complex regulatory network involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.